Medical Device Clinical Trials Market Growth Outlook Reveals A CAGR Of 7% And A Market Value Of $25.34 Billion By 2030
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Medical Device Clinical Trials Market Growth Potential: How Will Market Size Change Through 2030?
The medical device clinical trials sector has experienced robust expansion over recent years. Projected figures indicate an increase from $18.07 billion in 2025 to $19.36 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.2%. This historical growth has been driven by factors such as advancements in medical device innovation, strict regulatory approval processes, a heightened need for patient safety verification, the broadening of clinical research conducted within hospital settings, and greater funding directed toward the production of clinical evidence.
The market for clinical trials involving medical devices is projected to experience substantial expansion in the coming years. By 2030, its value is anticipated to reach $25.35 billion, reflecting a compound annual growth rate (CAGR) of 7.0%. This anticipated growth during the forecast period is driven by factors such as the rise of wearable and connected medical devices, heightened regulatory demands for device performance, the broadening of digital trial platforms, greater utilization of remote patient monitoring in studies, and the increasing globalization of clinical research. Key trends shaping the forecast period involve the growing adoption of decentralized clinical trials, enhanced integration of real-world evidence in device studies, a heightened emphasis on post-approval and long-term safety evaluations, the expansion of adaptive and hybrid trial frameworks, and a rising need for regulatory-compliant trial management processes.
Download A Free Sample Report For Comprehensive Market Insights:
#Medical Device Clinical Trials Market Growth Factors: Which Forces Are Supporting Market Expansion?
The growing incidence of chronic illnesses is anticipated to accelerate the expansion of the medical device clinical trials market in the foreseeable future. These conditions, characterized as long-term health issues that advance gradually and demand continuous medical attention, are becoming more widespread due to inactive lifestyles—where individuals spend extended periods seated at desks or using digital gadgets, resulting in reduced energy expenditure and compromised cardiovascular health, which in turn contributes to ailments like obesity, diabetes, and hypertension. This increase in chronic diseases fuels the necessity for medical device clinical trials aimed at creating and verifying novel instruments for efficient diagnosis, therapy, and oversight. For example, in June 2023, the Institute for Health Metrics and Evaluation, a public health research body based in the United States, disclosed that over half a billion people worldwide were afflicted with diabetes, a figure projected to exceed 1.3 billion by 2050. Consequently, the escalating frequency of chronic diseases is propelling the advancement of the medical device clinical trials market.
Medical Device Clinical Trials Market Segment Performance And Strategic Opportunities
The medical device clinical trials market covered in this report is segmented –
1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study
2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications
3) By Study Design: Interventional, Observational, Expanded Access
Subsegments:
1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing
2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials
3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies
4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies
Medical Device Clinical Trials Market Industry Trends: What Changes Are Reshaping Demand?
Key players in the medical device clinical trials market are increasingly concentrating on the creation of AI-driven medical device software to improve the efficiency of clinical trial protocols and resource management, thereby boosting trial effectiveness and lowering expenses. Such AI-powered software is utilized in healthcare settings, employing artificial intelligence algorithms—particularly machine learning or deep learning—to assist with or automate medical functions. A notable example occurred in January 2025, when Risklick, a pharmaceutical firm based in Switzerland, introduced Protocol AI, an artificial intelligence tool aimed at speeding up and refining clinical trials for medical devices. By leveraging Natural Language Processing (NLP) and Machine Learning (ML), Protocol AI examines clinical data, scientific publications, and regulatory materials, enabling the automatic generation of clinical trial protocols within minutes. This advancement dramatically cuts down the time and financial resources needed for protocol creation, a process that typically spans around six months, and has already achieved up to a 50% decrease in document development time for medicinal products.
Medical Device Clinical Trials Market Key Players: Which Companies Shape Industry Competition?
Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG
Access The Complete Medical Device Clinical Trials Market Report:
Medical Device Clinical Trials Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
